Tci Wealth Advisors, Inc. 9 Meters Biopharma, Inc. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$0.26 - $0.64 $78 - $192	300 Added 42.86%	1,000 $0
Q2 2021 Aug 02, 2021	SELL	$1.04 - $1.5 $1,040 - $1,500	-1,000 Reduced 58.82%	700 $1,000
Q1 2021 Apr 29, 2021	SELL	$0.84 - $2.16 $2,016 - $5,184	-2,400 Reduced 58.54%	1,700 $2,000
Q4 2020 Jan 21, 2021	BUY	$0.65 - $1.11 $1,040 - $1,776	1,600 Added 64.0%	4,100 $4,000
Q3 2020 Oct 20, 2020	BUY	$0.48 - $0.84 $1,200 - $2,100	2,500 New	2,500 $2,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.